(PRAP) Amundi Index Solutions - Ratings and Ratios
Exchange-Traded Funds, Corporate Bonds
Description: PRAP Amundi Index Solutions
Amundi Index Solutions Amundi Prime US Corporates UCITS ETF DR (C) is an exchange-traded fund (ETF) listed on XETRA, tracking the Morningstar US Corp Bd TR USD index. This ETF provides investors with exposure to a diversified portfolio of US corporate bonds, aiming to replicate the performance of the underlying index.
The fund is designed to offer a cost-effective and transparent way to invest in the US corporate bond market. By tracking the Morningstar US Corp Bd TR USD index, the ETF provides access to a broad range of investment-grade corporate bonds issued by US companies. The funds investment objective is to deliver returns that are in line with the underlying index, making it a suitable option for investors seeking to gain exposure to the US corporate bond market.
Analyzing the available
Combining the
To capitalize on this forecast, investors may consider accumulating the ETF on dips towards the 20-day SMA or lower, with a target price of 19.00 and a stop-loss below the 52-week low of 17.41. It is essential to continuously monitor the ETFs price action and adjust the investment strategy accordingly.
Additional Sources for PRAP ETF
PRAP ETF Overview
Market Cap in USD | 101m |
Category | USD Corporate Bond |
TER | 0.07% |
IPO / Inception | 2019-09-10 |
PRAP ETF Ratings
Growth Rating | -7.37 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | -0.59 |
Analysts | - |
Fair Price Momentum | 16.38 EUR |
Fair Price DCF | - |
PRAP Dividends
Currently no dividends paidPRAP Growth Ratios
Growth Correlation 3m | -19.9% |
Growth Correlation 12m | -22.2% |
Growth Correlation 5y | 8.7% |
CAGR 5y | -0.80% |
CAGR/Max DD 5y | -0.05 |
Sharpe Ratio 12m | 0.09 |
Alpha | -6.77 |
Beta | -0.040 |
Volatility | 83.87% |
Current Volume | 3.6k |
Average Volume 20d | 2.5k |
As of July 07, 2025, the stock is trading at EUR 17.72 with a total of 3,632 shares traded.
Over the past week, the price has changed by +0.08%, over one month by -1.08%, over three months by -4.43% and over the past year by -2.81%.
Neither. Based on ValueRay´s Analyses, Amundi Index Solutions is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -7.37 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of PRAP is around 16.38 EUR . This means that PRAP is currently overvalued and has a potential downside of -7.56%.
Amundi Index Solutions has no consensus analysts rating.
According to our own proprietary Forecast Model, PRAP Amundi Index Solutions will be worth about 17.7 in July 2026. The stock is currently trading at 17.72. This means that the stock has a potential downside of -0.17%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 17.7 | -0.2% |